Integra LifeSciences - Comparative Multiple Analysis

Integra LifeSciences (Comparative Multiple Analysis)


Notes on the Comparative Multiple Analysis of Integra LifeSciences

WikiWealth compares Integra LifeSciences's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Integra LifeSciences's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Integra LifeSciences.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Integra LifeSciences's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Integra LifeSciences's Analysis

How does this work? The Comparative Investment Analysis determines the value of Integra LifeSciences by comparing Integra LifeSciences financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Integra LifeSciences.

See the Integra LifeSciences cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Integra LifeSciences.

Also, see the Integra LifeSciences's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Integra LifeSciences's valuation conclusion for a quick summary.